Pacific Edge Ltd (PEB) - Product Pipeline Analysis, 2017 Update

Summary

Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is developing Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. PEB spans its expertise in molecular oncology, cancer genetics, bioinformatics, clinical research, technology commercialisation, marketing and sales, among others. The company offers diagnostic services through its facilities in New Zealand, Australia and the US, among others. PEB is headquartered in Dunedin, New Zealand.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Pacific Edge Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Pacific Edge Ltd Company Overview 5
Pacific Edge Ltd Company Snapshot 5
Pacific Edge Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Pacific Edge Ltd Pipeline Analysis Overview 8
Pacific Edge Ltd - Key Facts 8
Pacific Edge Ltd - Major Products and Services 9
Pacific Edge Ltd Pipeline Products by Development Stage 10
Pacific Edge Ltd Ongoing Clinical Trials by Trial Status 12
Pacific Edge Ltd Pipeline Products Overview 14
Cxbladder 14
Cxbladder Product Overview 14
Cxbladder Clinical Trial 15
Cxbladder - Health 16
Cxbladder - Health Product Overview 16
Cxbladder - Prognosis Assay 17
Cxbladder - Prognosis Assay Product Overview 17
Cxbladder Resolve 18
Cxbladder Resolve Product Overview 18
Cxcolorectal - Prognosis Gen I 19
Cxcolorectal - Prognosis Gen I Product Overview 19
Cxcolorectal - Prognosis Gen II 20
Cxcolorectal - Prognosis Gen II Product Overview 20
Diagnostic Assay - Gastric Cancer 21
Diagnostic Assay - Gastric Cancer Product Overview 21
Endometrial Cancer Detection Assay 22
Endometrial Cancer Detection Assay Product Overview 22
Gastric Cancer Triage Immunoassay 23
Gastric Cancer Triage Immunoassay Product Overview 23
Prognostic Assay - Melanoma 24
Prognostic Assay - Melanoma Product Overview 24
Pacific Edge Ltd - Key Competitors 25
Pacific Edge Ltd - Key Employees 26
Pacific Edge Ltd - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Pacific Edge Ltd, Recent Developments 28
Aug 03, 2017: Cxbladder Test Suite Adopted by MidCentral DHB 28
Apr 12, 2017: Cxbladder Monitor Significantly Outperforms All Compared FDA Approved Urine Tests For Bladder Cancer; Enhancing The Standard Of Care For Bladder Cancer Patients 28
Dec 15, 2016: Pacific Edge Launches Cxbladder Resolve - The Fourth Product in Suite of Cxbladder Tests 29
Dec 13, 2016: Pacific Edge Commences Official Launch Of Cxbladder Monitor In The USA 30
Nov 24, 2016: Pacific Edge Interim Results to 30 September 2016 31
Nov 14, 2016: Positive Results in Kaiser Permanente User Programme 32
Nov 03, 2016: PE Announces User Programme with Singapore General Hospital 33
Oct 25, 2016: Cxbladder Monitor Adopted by Waitemata District Health Board 33
Aug 25, 2016: Chris Gallaher Elected as New Chairman for Pacific Edge Board 34
Jun 02, 2016: Pacific Edge Board Changes Announced 34
Appendix 36
Methodology 36
About GlobalData 38
Contact Us 38
Disclaimer 39

List Of Tables


Pacific Edge Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Pacific Edge Ltd Pipeline Products by Equipment Type 6
Pacific Edge Ltd Pipeline Products by Indication 7
Pacific Edge Ltd Ongoing Clinical Trials by Trial Status 7
Pacific Edge Ltd, Key Facts 8
Pacific Edge Ltd, Major Products and Services 9
Pacific Edge Ltd Number of Pipeline Products by Development Stage 10
Pacific Edge Ltd Pipeline Products Summary by Development Stage 11
Pacific Edge Ltd Ongoing Clinical Trials by Trial Status 12
Pacific Edge Ltd Ongoing Clinical Trials Summary 13
Cxbladder - Product Status 14
Cxbladder - Product Description 14
Cxbladder - A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urothelial Carcinoma (UC) 15
Cxbladder - Health - Product Status 16
Cxbladder - Health - Product Description 16
Cxbladder - Prognosis Assay - Product Status 17
Cxbladder - Prognosis Assay - Product Description 17
Cxbladder Resolve - Product Status 18
Cxbladder Resolve - Product Description 18
Cxcolorectal - Prognosis Gen I - Product Status 19
Cxcolorectal - Prognosis Gen I - Product Description 19
Cxcolorectal - Prognosis Gen II - Product Status 20
Cxcolorectal - Prognosis Gen II - Product Description 20
Diagnostic Assay - Gastric Cancer - Product Status 21
Diagnostic Assay - Gastric Cancer - Product Description 21
Endometrial Cancer Detection Assay - Product Status 22
Endometrial Cancer Detection Assay - Product Description 22
Gastric Cancer Triage Immunoassay - Product Status 23
Gastric Cancer Triage Immunoassay - Product Description 23
Prognostic Assay - Melanoma - Product Status 24
Prognostic Assay - Melanoma - Product Description 24
Pacific Edge Ltd, Key Employees 26
Pacific Edge Ltd, Subsidiaries 27
Glossary 37

List Of Figures


Pacific Edge Ltd Pipeline Products by Equipment Type 6
Pacific Edge Ltd Pipeline Products by Development Stage 10
Pacific Edge Ltd Ongoing Clinical Trials by Trial Status 12

Pacific Edge Ltd (PEB) - Product Pipeline Analysis, 2019 Update

Pacific Edge Ltd (PEB) - Product Pipeline Analysis, 2019 Update market research report available in single user pdf license with Aarkstore Enterprise at USD 750

USD 750 View Report

Asia Pacific Edge ROADM Revolution Products Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Edge ROADM Revolution Products market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million

USD 3000 View Report

Pacific Edge Ltd (PEB) - Product Pipeline Analysis, 2019 Update

Pacific Edge Ltd (PEB) - Product Pipeline Analysis, 2019 Update market research report available in single user pdf license with Aarkstore Enterprise at USD 750

USD 750 View Report

Asia Pacific Edge ROADM Revolution Products Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Edge ROADM Revolution Products market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available